Black Diamond Therapeutics, Inc.
BDTX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
149.99M
▲7.47M▲5.24%
3 Months ChangeLiabilities
38.97M
▲750.00k▲1.96%
3 Months ChangeFree Cash Flow
-20.03M
▲8.58M▲29.98%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-07
Form 8-K
ID: 0001104659-24-106676
2024-09-23
Form 8-K
ID: 0001104659-24-101874
2024-08-06
Form 10-Q
ID: 0001701541-24-000030
2024-08-06
Form 8-K
ID: 0001701541-24-000028
2024-06-06
Form 8-K
ID: 0001104659-24-069070
2024-05-09
Form 10-Q
ID: 0001701541-24-000022
2024-05-09
Form 8-K
ID: 0001701541-24-000020
2024-04-11
Form 8-K
ID: 0001104659-24-046096
2024-03-12
Form 8-K
ID: 0001701541-24-000009
2024-01-18
Form 8-K
ID: 0001104659-24-004802